Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals.


Diabetic retinopathy at diagnosis of T2D in the UK

October 11th 2012

Diabetic retinopathy was diagnosed in about one out of five patients with type 2 diabetes during the first year after diabetes diagnosis in UK general practices. Age, male sex, hyperglycaemia and hypertension were identified as risk factors of early retinopathy in type 2 diabetes (Diabetologia)

Categories: News, Ophthalmology

Categories: Ophthalmology

Effect of T2D on risk of hepatocellular carcinoma in chronic Hep C

October 11th 2012

T2DM causes an approximately 1.7-fold enhancement in the development of HCC and malignancies other than HCC in HCV-positive patients treated with IFN (Hepatology)

Categories: Hepatology, News

Categories: Hepatology

Glycated albumin superior to H1C for severity coronary artery disease T2D

October 9th 2012

Serum GA level is a better indicator than HbA1c for evaluating the presence and severity of CAD and predicting major adverse cardiac events in patients with T2DM (Cardiology)

Categories: Cardiovascular, News

Categories: Cardiovascular

Identification of Serum Metabolites Associated With Risk of T2D

October 9th 2012

The data indicate that metabolic alterations, including sugar metabolites, amino acids, and choline-containing phospholipids, are associated early on with a higher risk of T2D (Diabetes)

Categories: News, Screening

Categories: Screening

Gestational diabetes: The public health relevance and approach

October 9th 2012

A great understanding of the importance of GDM and its consequences by the Government and public will go a long way in containing the epidemic of diabetes (Diabetes Research and Clinical Practice)

Categories: Gestational, News

Categories: Gestational

Setting research priorities for Type 1 diabetes

October 9th 2012

We have shown that it is possible using the James Lind Alliance process to develop an agreed top 10 list of research priorities for Type 1 diabetes from health professionals, patients and carers (Diabetic Medicine)

Categories: News, Research

Categories: Research

Mitochondrial exchanger upregulates glucose dependent ca2+ signalling

October 9th 2012

These findings suggest that the mitochondrial Na+/Ca2+ exchanger, NCLX, shapes glucose-dependent mitochondrial and cytosolic Ca2+ signals thereby regulating the temporal pattern of insulin secretion in ß cells (PLoS ONE)

Categories: Biochemistry, News

Categories: Biochemistry

Use of Thiazolidinediones & Risk of Colorectal Cancer

October 8th 2012

A nationwide, population-based, case-control study found that the use of TZDs may be associated with a decreased risk of colorectal cancer in patients with diabetes (Diabetes Care)

Categories: News, Research

Categories: Research

Boston Therapeutics Wins FDA Approval for PAZAMET

October 8th 2012

In addition, the FDA has ruled that no further clinical investigation is necessary to demonstrate the safety and effectiveness of this proposed product (Boston Therapeutics)

Categories: Medication, News

Categories: Medication

Outpatient electronic health records and clinical care and outcomes

October 5th 2012

Use of a commercially available certified EHR was associated with improved drug treatment intensification, monitoring, and physiologic control among patients with diabetes, with greater improvements among patients with worse control and less testing in patients already meeting guideline-recommended glycemic and lipid targets (Annals of Internal Medicine)

Categories: Management, News

Categories: Management

Association between liver insulin resistance & cardiovascular risk factors

October 4th 2012

Liver IR index correlated more strongly than Matsuda ISI with levels of total cholesterol, CRP and triglycerides. Therefore, liver IR might be a significant indicator of CVD risk amongst men (Journal of Internal Medicine)

Categories: Monitoring, News

Categories: Monitoring

Moderate-intensity physical activity ameliorates breast cancer risk

October 4th 2012

Moderate-intensity physical activity can substantially ameliorate the increased BC risk in diabetic women (Diabetes Care)

Categories: News, Treatment

Categories: Treatment

Screening for type 2 diabetes doesn’t affect mortality at 10 years

October 4th 2012

Screening middle aged people for type 2 diabetes has no overall effect on the number who die over the next 10 years, concludes a study by the UK Medical Research Council (BMJ)

Categories: News, Screening

Categories: Screening

Starting injectable treatment in adults with Type 2 diabetes: RCN guidance

October 2nd 2012

This new edition provides information relating to GLP 1 therapy action, including the implications for use and the aspects of education that need to be addressed with users. This guidance is intended for nurses new to insulin therapy, and includes an overview of the underlying principles for starting insulin along with practical tips on education, adjustment of doses, and dealing with difficult situations (RCN)

Categories: Guidance, News

Categories: Guidance

Outcomes Data for Investigational Novel Basal Insulin Analogue

October 2nd 2012

The study results showed that in addition to clinical results showing a statistically significant 48 percent baseline adjusted reduction in nocturnal hypoglycaemia compared with insulin glargine patients treated with LY2605541* reported a statistically significant reduction in the anxiety and fear associated with experiencing a hypoglycaemic event based upon the Adult Low Blood Sugar Survey (Lilly)

Categories: Medication, News

Categories: Medication

Studies assess linagliptin treatment in adults with T2D

October 2nd 2012

The new analyses show linagliptin, alone or in combination with other diabetes therapies, lowered hemoglobin A1c (HbA1c or A1C) in elderly patients with type 2 diabetes, as well as in adults with type 2 diabetes with diabetic nephropathy (renal disease).Data from a fourth study found adding linagliptin to a stable dose of basal insulin improved blood glucose control over 52 weeks without an additional risk of hypoglycemia or weight gain compared to placebo (Lilly)

Categories: Medication, News

Categories: Medication

Facilitating children’s contributions in clinic

October 2nd 2012

Findings have implications for facilitating children’s contributions in clinic, understanding how ideas about children are reproduced in clinical settings and supporting clinicians to engage with the capacities and priorities of children living with long-term illness (Diabetic Medicine)

Categories: Management, News

Categories: Management

A comparison of cost per case detected of screening strategies T2D

October 2nd 2012

Screening a population using a non-invasive risk stratification tool followed by a screening blood test is the most cost-effective method of screening for diabetes and abnormal glucose tolerance (Diabetes Research and Clinical Practice)

Categories: News, Research

Categories: Research

Exploring the understanding of evidence-based concepts in T2D

October 1st 2012

Participants had a poor understanding of most of the evidence-based concepts in type 2 diabetes that were explored. This disadvantages them in being able to make informed decisions about their health care and actively manage their diabetes (International Journal of General Medicine)

Categories: Management, News

Categories: Management

Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Diabetes & CKD

October 1st 2012

Intensive glycemic control and lipid interventions did not improve clinical outcomes in patients with type 2 diabetes (American Journal of Kidney Diseases)

Categories: News, Treatment

Categories: Treatment
  • « Previous Page
  • 1
  • …
  • 224
  • 225
  • 226
  • 227
  • 228
  • …
  • 239
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

AstraZenecaBoehringer IngelheimNapp DiabetesNovo Nordisk

Silver Sponsors

About Ascensia Diabetes CareAbbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

News Archive

calendar-iconNews Archive ››

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Recent Book and Product Reviews

  • Roxburgh’s Common Skin Diseases 19th Edition
  • Oxford Handbook of Clinical Surgery 5th edition
  • Oxford Handbook of Medical Ethics and Law
  • Textbook of Emergency Cardiology

Recent Diabetes Updates

  • National Diabetes Audit.
  • Funding bids
  • Publication of Studies During 2016 – Type 2 Diabetes
  • “Attitudes to obesity” findings from the 2015 survey

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


Website by Wired up Wales

Copyright © 2022 Glycosmedia Partnership